Is this you? Create Your Porfile
Avatar

G. De Smedt

Janssen Pharmaceutica

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where G. De Smedt is active.

Explore More

Publication

Featured researches published by G. De Smedt.

European Neuropsychopharmacology | 1995

P-4-76 Risperidone in the treatment of first-episode patients with schizophreniform disorder: A double-blind multicenter study

Robin Emsley; R. McCreadie; M. Livingston; G. De Smedt; P. Lemmens

Schizophrenia Research | 1998

Risperidone in the treatment of behavioral disturbances in dementia

P.P. De Deyn; P. Lemmens; G. De Smedt

Schizophrenia Research | 2003

Prolactin levels in children after long term treatment with risperidone

Robert L. Findling; Michael G. Aman; V. Kusumakar; Denis Daneman; Thomas Moshang; G. De Smedt; Carin Binder

European Neuropsychopharmacology | 2003

P.2.136 Premorbid functioning and outcomes in recent onset schizophrenia

Jonathan Rabinowitz; G. De Smedt; Michael Davidson

European Psychiatry | 2002

Risperidone in children with conduct problems and subaverage IQ

R.L. Findling; Michael G. Aman; G. De Smedt; A. Derivan

European Psychiatry | 2002

Risperidone in children with disruptive behaviors and subaverage IQ

R.L. Findling; Joerg M. Fegert; G. De Smedt

European Neuropsychopharmacology | 2001

Risperidone in children with significant conduct problems and subaverage intellectual functioning

Robert L. Findling; Michael G. Aman; G. De Smedt; A. Derivan

European Neuropsychopharmacology | 1998

Psychosis and behavioral disturbances in dementia: Effects of risperidone in 969 patients

P.P. De Deyn; G. De Smedt; M. Brecher

European Neuropsychopharmacology | 1995

P-4-75 Therapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia

B. Jones; G. De Smedt; P. Lemmens

European Neuropsychopharmacology | 2003

P.2.023 Prolactin levels in children after long-term treatment with risperidone

Robert L. Findling; V. Kusumakar; Denis Daneman; Thomas Moshang; G. De Smedt; Carin Binder

Explore More

Collaboration

Dive into the G. De Smedt's collaboration.

Top Co-Authors
Avatar

Robert L. Findling

Johns Hopkins University

View shared research outputs
Top Co-Authors
Avatar

Michael G. Aman

Ohio State University

View shared research outputs
Top Co-Authors
Avatar

V. Kusumakar

Johnson

View shared research outputs
Top Co-Authors
Avatar

Carin Binder

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

P.P. De Deyn

University of Antwerp

View shared research outputs
Top Co-Authors
Avatar

R.L. Findling

University Hospitals of Cleveland

View shared research outputs
Top Co-Authors
Avatar

Thomas Moshang

University of Pennsylvania

View shared research outputs
Top Co-Authors
Avatar

Denis Daneman

University of Toronto

View shared research outputs
Top Co-Authors
Avatar

A. Derivan

Janssen Pharmaceutica

View shared research outputs
Top Co-Authors
Avatar

Michael Davidson

University of Chicago

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge